Director of Endocrinology, Nanjing Drum Tower Hospital
Current President, Chinese Diabetes Society
Published articles in numerous prestigious journals such as the Lancet Diabetes and Endocrinology,Diabetes
Director of Endocrinology, Director of Department of Internal Medicine, Vice Chairman of Ethics Committee at China-Japan Friendship Hospital
Ex President, Chinese Diabetes Society
Published articles in numerous prestigious journals such as New England Journal of Medicine, Lancet Diabetes and Endocrinology
Director of Endocrinology, Zhongshan Hospital
Vice President, Chinese Diabetes Society
Published articles in numerous prestigious journals such as the Lancet Diabetes and Endocrinology,Cell Metabolism
Professor of biochemistry and biophysics at the University of Pennsylvania, Perelman School of Medicine
Founded Penn Diabetes Research Center of the University of Pennsylvania
Founder of the Islet Cell Biology Core in the University of Pennsylvania
Received Banting Award (1995)
Formulated the glucokinase glucose sensor concept “Glucokinase is a glucose sensor, diabetes gene and drug target”
Professor and Division Chief of Diabetes Division at the University of Texas Health Science Center
Deputy Director of Texas Diabetes Institute
Led the U.S. development of metformin, and FDA approval in 1995
Discovered a new approach to diabetes treatment that targets glucose reabsorption in the kidneys, which led to the development and approval of SGLT-2
Received several prestigious awards, including the Lilly Award (1987) by the American Diabetes Association, Banting Lectureship Award (1988) by the Canadian Diabetes Association, Novartis Award (2003), ADA’s Albert Renold Award (2002), the ADA’s Banting Award (2008), and the Harold Hamm International Prize (2018)
Published over 800 articles in peer-reviewed medical journals